Elizabeth Burr - Rite Aid Independent Director

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

Downward Rally

  Director
Ms. Elizabeth Burr is Director of the Company
Age: 56  Director Since 2019  MBA    
717 975-5905  www.riteaid.com
Burr most recently served as the chief innovation officer and vice president of healthcare trend and innovation at Humana where she was responsible for driving the design, build and adoption of new product platforms in digital health, provider experience, and telemedicine, to improve health outcomes, create superior member experiences, and improve health care costs. She also founded Humana?s strategic investing practice, Humana Health Ventures. Prior to joining Humana in 2015, Burr was managing director of Citi Ventures and led largescale business transformation efforts as the global head of Citi?s Business Incubation FunctionDesignWorks. Earlier in her career, Burr spent seven years in investment banking at Morgan Stanley and Credit Suisse First Boston and previously served as vice president of global brand management at Gap, Inc. Burr holds an MBA from Stanford University and a bachelor?s degree in Economics from Smith College. Burr serves on the Boards of Mr

Elizabeth Burr Latest Insider Activity

Rite Aid Management Efficiency

Rite Aid has Return on Asset of 1.72 % which means that on every $100 spent on asset it made $1.72 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (53.68) %, meaning that it generated no profit with money invested by stockholders. Rite Aid management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Rite Aid Return on Invested Capital is expected to slightly increase based on the last few years of reporting. The past year's Return on Invested Capital was at 0.07. The current year Return on Sales is expected to grow to 0.0301, whereas Return on Average Assets are expected to decline to (5.45) . Rite Aid Goodwill and Intangible Assets are expected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 447.84 Million. The current year Revenue to Assets is expected to grow to 2.98, whereas Assets Non Current are expected to decline to about 3.8 B. Rite Aid Tax Liabilities is expected to increase significantly based on the last few years of reporting. The past year's Tax Liabilities was at 66.34 Million
The company has 6.53 B in debt. Rite Aid has a current ratio of 1.44, which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

DIRECTOR Since

Javier TeruelJ C Penney
2008
Eugene DavisSpectrum Brands Holdings
2010
Nelson PeltzSysco
2015
Hugh RovitSpectrum Brands Holdings
2018
Joseph MagnaccaSally Beauty Holdings
2017
Edward RabinSally Beauty Holdings
2006
Kenneth SalazarTarget
2013
David GibbsSally Beauty Holdings
2016
Daniel BruttoSysco
2016
Yu XuVipshop Holdings Limited
2008
Lawrence MolloySprouts Farmers Market
2019
Terry PolistinaSpectrum Brands Holdings
2018
Kelly MooneySally Beauty Holdings
2018
Robert EdwardsTarget
2015
Joseph OLearySprouts Farmers Market
2017
Anne MulcahyTarget
1997
John CassadaySysco
2004
Joseph HafnerSysco
2003
Erin CoxSally Beauty Holdings
2016
Debora PlunkettJ C Penney
2017
Wonya LucasJ C Penney
2017

Company Summary

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in the United States and is traded on BATS Exchange. It employs 29840 people.Rite Aid (RAD) is traded on BATS Exchange in USA and employs 29,840 people.

Rite Aid Leadership Team

Heyward Donigan, President, Chief Executive Officer, Director
Joseph Anderson, Independent Director
Elizabeth Burr, Independent Director
Douglas Donley, Chief Accounting Officer, Senior Vice President
Jim Peters, Chief Operating Officer
Michael Regan, Lead Independent Director
Arun Nayar, Independent Director
Brian Hoover, Chief Accounting Officer
David Jessick, Independent Director
Katherine Quinn, Independent Director
Myrtle Potter, Director
Bruce Bodaken, Independent Chairman of the Board
Kevin Lofton, Independent Director
Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer
David Abelman, Executive Vice President - Marketing
Frank Savage, Independent Director
Kermit Crawford, President COO
Marcy Syms, Independent Director
James Comitale, Senior Vice President General Counsel, Secretary
Steve Rempel, Senior Vice President CIO
Justin Mennen, Senior Vice President, Chief Information Officer
Dedra Castle, Chief Human Resource Officer, Executive Vice President
Erik Keptner, Senior Vice President Chief Marketing Officer
Marc Strassler, Corporate Counsel
Kenneth Martindale, Pres and CEO of Rite Aid Stores
Derek Griffith, Executive Vice President - Store Operations
Enio Montini, Executive Vice President - Merchandising
Louis Miramontes, Independent Director
Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP
Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations
Matthew Schroeder, Chief Financial Officer, Senior Vice President
Robert Knowling, Independent Director
Andre Persaud, Executive Vice President - Retail
Bryan Everett, Executive Vice President - Store Operations
Doug Donley, Chief Accounting Officer, Senior Vice President
John Standley, Chairman, CEO and Chairman of Executive Committee
James Peters, Chief Operating Officer

Stock Performance Indicators

Current Sentiment - RAD

Rite Aid Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Rite Aid. What is your perspective on investing in Rite Aid? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

S   
Sold over 300 shares of
few days ago
Traded for 8.62
GM   
Sold over 100 shares of
few days ago
Traded for 25.24
XOM   
Sold over 60 shares of
few days ago
Traded for 44.08
OTPBF   
Sold over 100 shares of
few days ago
Traded for 28.82
MSFT   
Sold few shares of
few days ago
Traded for 206.26
Additionally, take a look at Your Equity Center. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page